Astellas Pharma Balance Sheet - Annual (OTCMKTS:ALPMY)

Add to My Stocks
$17.5 $0.51 (3%) ALPMY stock closing price Sep 18, 2018 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like Astellas Pharma, and helps in stock analysis. A balance sheet can help evaluate the financial performance of a company. Ratios like return on total assets and current ratio, which also uses cash on hand can be used to measure the operating efficiency of a firm, and can be used to conduct a more accurate Astellas Pharma stock analysis. A company releases its balance sheet every year along with its annual results. The Astellas Pharma balance sheet for 2017 shows total assets of $16.26B. The company has a asset turnover ratio of 0.72. Also see: Astellas Pharma revenue and Astellas Pharma operating cash flow for the same year.

View latest 10 year balance sheet data to check Astellas Pharma financial performance.
show more
View Previous Years
View Next Years
Fiscal year is Apr - Mar201720162015201420132012
Marketable Securities121M119.47M545.16M344M508M570M
Raw Materials---231.38M236.55M-
Work In Progress---151.43M141.28M-
Finished Goods---930.06M985.77M-
Notes Receivable------
Other Current Assets168M144.59M117.12M155M917M1.05B
Total Current Assets
Property Plant & Equipment---4.37B5.88B-
Accumulated Depreciation---2.51B3.56B-
Net Property Plant & Equipment
Investment & Advances577M762.42M1.02B940M666M745M
Other Non-Current Assets199M200.05M141.85M---
Deferred Charges807M666.09M465.91M442M289M413M
Deposits & Other Assets117M122.58M124.53M89M162M136M
Total Assets
Notes Payable------
Accounts Payable1.63B1.51B2.06B1.82B2.03B2.33B
Current Portion Long-Term Debt------
Current Portion Capital Leases27M12.49M12.18M10M--
Accrued Expenses----1.05B1.04B
Income Taxes Payable97M160.28M128.52M129M-302M
Other Current Liabilities1.81B1.75B1.63B1.35B256M166M
Total Current Liabilities
Deferred Taxes/Income226M---369M377M
Convertible Debt------
Long-Term Debt------
Non-Current Capital Leases253M5.99M5.69M7M--
Other Long-Term Liabilities853M1.05B492.38M419M376M457M
Total Liabilities
Minority Interest------
Preferred Stock------
Common Stock Net920M854.9M937.3M1B1.1B1.26B
Capital Surplus1.58B1.47B1.61B1.72B1.88B2.16B
Retained Earnings9.05B8.08B8.24B8.4B9.76B10.91B
Treasury Stock1.23B1.3B791.67M529M769M282M
Other Liabilities1.04B1.36B2B1.73B-671M-1.63B
Shareholders Equity11.36B10.45B11.99B12.32B11.3B12.42B
Total Liabilities & Shareholders Equity16.26B14.93B16.32B16.05B15.38B17.08B
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Most investors just check the Astellas Pharma stock price, and Astellas Pharma historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Astellas Pharma PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: ALPMY total assets, which was at $16.26B for 2017 is a balance sheet item representing value of what Astellas Pharma owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. ALPMY stock had total liabilities of $4.9B for the year 2017.

Astellas Pharma Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio

Annual Balance Sheets For ASTELLAS PHARMA UNSP ADR EACH REPR 0.25 ORD Peers

Astrazeneca balance sheet, Eisai balance sheet, Pfizer balance sheet, Shire balance sheet, Zoetis balance sheet